Volpara Health Technologies Limited
VPAHF · OTC
9/30/2023 | 3/31/2023 | 9/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 4.47 | 0.83 | 0.19 | 1.13 |
| FCF Yield | 0.17% | 0.45% | -5.20% | -2.80% |
| EV / EBITDA | -92.54 | -66.85 | -50.01 | -46.57 |
| Quality | ||||
| ROIC | -8.72% | -7.65% | -12.26% | -12.53% |
| Gross Margin | 76.79% | 77.30% | 76.24% | 73.57% |
| Cash Conversion Ratio | -0.29 | -0.45 | 1.14 | 0.74 |
| Growth | ||||
| Revenue 3-Year CAGR | 113.77% | 3,837,642.43% | 3,670,874.38% | 3,504,815.19% |
| Free Cash Flow Growth | -63.24% | 112.24% | -8.06% | 5.07% |
| Safety | ||||
| Net Debt / EBITDA | 4.15 | 3.84 | 3.02 | 3.27 |
| Interest Coverage | -74.11 | -34.17 | -34.29 | -110.07 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 2.98 | 0.00 | -923,453,402,120,192.00 |
| Cash Conversion Cycle | -44.73 | 61.39 | -16.42 | 41.07 |